Topical Lovastatin new primary treatment option for patients of Disseminated Superficial Actinic Porokeratosis
A new study found that there were no significant benefits in clinical improvements in Disseminated superficial actinic porokeratosis (DSAP) after adding cholesterol 2% cream to 2% lovastatin instead of plain lovastatin alone. The clinical improvements were almost similar in both groups as per the study results that were published in the journal JAMA Dermatology. Disseminated […] More